Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

480 public trials 127 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, Not Recruiting

First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors

NCT05489237

Conditions
Digestive System Disease, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

Pilot Randomized Clinical Trial of Informational Support Versus Spiritual Care

NCT07176559

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +10 more
Locations
  • IU Health Joe and Shelly Schwarz Cancer Center Carmel, Indiana, United States
  • Indiana University Melvin & Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
  • IU Health Arnett Hospital Lafayette, Indiana, United States
View Trial Details
Active, Not Recruiting

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

NCT04607421

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +10 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona - Scottsdale Scottsdale, Arizona, United States
  • Keck Hospital of USC Los Angeles, California, United States
  • LAC & USC Medical Center Los Angeles, California, United States
View all 272 locations
View Trial Details
Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details

Related conditions